PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
Clinical trial NCT04711434 · UNKNOWN
Trial details
- NCT number
- NCT04711434
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2023-12-31
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.